U.S. Markets open in 2 hrs 54 mins
  • S&P Futures

    4,402.00
    +8.25 (+0.19%)
     
  • Dow Futures

    34,979.00
    +145.00 (+0.42%)
     
  • Nasdaq Futures

    15,000.50
    -11.00 (-0.07%)
     
  • Russell 2000 Futures

    2,242.70
    +22.00 (+0.99%)
     
  • Crude Oil

    72.79
    +0.40 (+0.55%)
     
  • Gold

    1,827.10
    +22.50 (+1.25%)
     
  • Silver

    25.56
    +0.68 (+2.73%)
     
  • EUR/USD

    1.1879
    +0.0032 (+0.2732%)
     
  • 10-Yr Bond

    1.2610
    0.0000 (0.00%)
     
  • Vix

    17.61
    -1.75 (-9.04%)
     
  • GBP/USD

    1.3955
    +0.0046 (+0.3321%)
     
  • USD/JPY

    109.8500
    -0.0600 (-0.0546%)
     
  • BTC-USD

    40,297.69
    +212.03 (+0.53%)
     
  • CMC Crypto 200

    943.90
    +13.97 (+1.50%)
     
  • FTSE 100

    7,082.70
    +66.07 (+0.94%)
     
  • Nikkei 225

    27,782.42
    +200.76 (+0.73%)
     

ZYNE FINAL DEADLINE: ROSEN LAW FIRM Reminds Zynerba Pharmaceuticals, Inc. Investors of Important Deadline Today in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ZYNE

NEW YORK, Dec. 23, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zynerba Pharmaceuticals, Inc. (ZYNE) between March 11, 2019 and September 17, 2019, inclusive (the “Class Period”) of the important December 23, 2019 lead plaintiff deadline in securities class action. The lawsuit seeks to recover damages for Zynerba investors under the federal securities laws.

To join the Zynerba class action, go to http://www.rosenlegal.com/cases-register-1704.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR’S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Zygel was proving unsafe and not well-tolerated in the BELIEVE 1 Trial; (2) the foregoing created a foreseeable, heightened risk that Zynerba would fail to secure the necessary regulatory approvals for commercializing Zygel for the treatment of DEE in children and adolescents; and (3) as a result, Zynerba’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 23, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1704.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or cases@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com